EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.B9 | Acute Lung Injury |
25063875 |
ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
1
0 |
| 3.4.24.B9 | Adenocarcinoma |
14997207 |
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
2
0 |
| 3.4.24.B9 | Adenocarcinoma |
19473694 |
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
1 |
| 3.4.24.B9 | Adenocarcinoma |
21494182 |
ADAM-9 expression in intestinal-type adenocarcinoma of the sinonasal tract. |
causal interaction
unassigned |
3
0 |
| 3.4.24.B9 | Adenocarcinoma |
29550974 |
The pleiotropic roles of ADAM9 in the biology of solid tumors. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
4 |
| 3.4.24.B9 | Adenocarcinoma |
30556643 |
ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
3
2 |
| 3.4.24.B9 | Adenocarcinoma of Lung |
24705471 |
ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells. |
causal interaction
therapeutic application
unassigned |
3
2
0 |
| 3.4.24.B9 | Adenocarcinoma of Lung |
28675123 |
ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
1
4 |
| 3.4.24.B9 | Adenocarcinoma of Lung |
30038506 |
MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9). |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
1
1
0 |
| 3.4.24.B9 | Adenocarcinoma of Lung |
34055989 |
mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9. |
ongoing research
unassigned |
4
0 |
